Allurion Technologies (NYSE: ALUR) shares are moving higher Friday potentially after after the company announced plans to ...

Allurion Technologies (ALUR) stock climbed 200% despite a ~7.4M stock and warrants offering announced by the company. Read ...

Allurion (ALUR) stock soared 70% after the company announced it is planning to conduct a clinical study of its gastric balloon weight-loss product in combination with GLP-1 drugs.

Shantanu Gaur, the founder and chief executive of Allurion, said the goal of the study would be to prove that combining the Allurion Balloon and Allurion Virtual Care Suite with GLP-1 therapy would ...

Shares in the NYSE-listed company rose 77% at market open on 24 January 2025, compared to a market close, which occurred shortly after Allurion made the announcement. It is the highest price the ...

The news has given Allurion Technologies investors something to cheer about after they watched the shares sink rapidly since they hit a record high right after they began trading in the summer of ...

Co-primary endpoints based on Allurion Balloon subject responders and a comparison of percent total body weight loss between groups were measured at Week 48, approximately eight weeks after the ...

--(BUSINESS WIRE)--Allurion Technologies, Inc. (“Allurion” or the ... The gross proceeds to the Company from this offering are expected to be approximately $7.4 million, before deducting the placement ...

--(BUSINESS WIRE)-- Allurion Technologies ... from this offering are expected to be approximately $7.4 million, before deducting the placement agent’s fees and other offering expenses payable ...